NHO Iwakuni Clinical Center

Iwakuni-shi, Yamaguchi 740-8510

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Non Small Cell Lung Cancer

Studies at this site

• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations — Running, not enrolling